Lisa Marie Reindl

CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma

Tobias Bexte, Jamal Alzubi, Lisa Marie Reindl et al. · OncoImmunology · 2022 · 74 citations · Full text

Adjuvant therapy for gastric adenocarcinoma with the apoptosis-inducing human monoclonal antibody SC-1: first clinical and histopathological results.

H. Peter Vollmers, U. Zimmermann, Veit Krenn et al. · Oncology Reports · 1998 · 52 citations

Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectors

Tobias Bexte, Lacramioara Botezatu, Csaba Miskey et al. · Molecular Therapy · 2024 · 35 citations · Full text

Engineering, Medicine, Synthetic Biology +9

Pediatric multicellular tumor spheroid models illustrate a therapeutic potential by combining BH3 mimetics with Natural Killer (NK) cell-based immunotherapy

Vinzenz Särchen, Senthan Shanmugalingam, Sarah Kehr et al. · Cell Death Discovery · 2022 · 21 citations · Full text

Non-Viral <i>Sleeping Beauty</i> Transposon Engineered CD19-CAR-NK Cells Show a Safe Genomic Integration Profile and High Antileukemic Efficiency

Tobias Bexte, Lacramioara Botezatu, Csaba Miskey et al. · Blood · 2021 · 12 citations